Free Trial

CHURCHILL MANAGEMENT Corp Takes Position in Hinge Health Inc. $HNGE

Hinge Health logo with Medical background

Key Points

  • CHURCHILL MANAGEMENT Corp has purchased 15,996 shares of Hinge Health Inc. valued at approximately $828,000 in the second quarter.
  • Hinge Health's stock price is currently up 8.2%, with a 12-month high of $62.18 and a consensus target price of $57.13 among analysts.
  • Several firms have raised their price targets for Hinge Health, with Bank of America increasing its target from $42.00 to $64.00, reflecting heightened confidence in the stock's performance.
  • Five stocks to consider instead of Hinge Health.

CHURCHILL MANAGEMENT Corp bought a new position in shares of Hinge Health Inc. (NYSE:HNGE - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 15,996 shares of the company's stock, valued at approximately $828,000.

Hinge Health Stock Up 8.2%

NYSE HNGE opened at $52.74 on Friday. Hinge Health Inc. has a 12-month low of $33.42 and a 12-month high of $62.18. The firm has a 50-day simple moving average of $54.48.

Analyst Upgrades and Downgrades

A number of research firms have commented on HNGE. JMP Securities lifted their price objective on shares of Hinge Health from $58.00 to $65.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. Bank of America lifted their target price on shares of Hinge Health from $42.00 to $64.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Barclays increased their price target on shares of Hinge Health from $51.00 to $62.00 and gave the company an "overweight" rating in a report on Wednesday, August 6th. Stifel Nicolaus raised their price objective on shares of Hinge Health from $63.00 to $66.00 and gave the stock a "buy" rating in a research report on Thursday, September 11th. Finally, Robert W. Baird assumed coverage on Hinge Health in a research report on Friday, September 5th. They issued a "neutral" rating and a $56.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $57.13.

Read Our Latest Research Report on Hinge Health

Hinge Health Profile

(Free Report)

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

Featured Stories

Want to see what other hedge funds are holding HNGE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hinge Health Inc. (NYSE:HNGE - Free Report).

Institutional Ownership by Quarter for Hinge Health (NYSE:HNGE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Hinge Health Right Now?

Before you consider Hinge Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.

While Hinge Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.